| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 8 | 2024 | 149 | 4.350 |
Why?
|
| DNA-Binding Proteins | 17 | 2024 | 2061 | 3.060 |
Why?
|
| TDP-43 Proteinopathies | 6 | 2024 | 11 | 1.740 |
Why?
|
| C9orf72 Protein | 3 | 2023 | 24 | 1.680 |
Why?
|
| Alzheimer Disease | 9 | 2023 | 798 | 1.520 |
Why?
|
| Spinal Cord | 3 | 2021 | 304 | 1.380 |
Why?
|
| Brain Neoplasms | 6 | 2018 | 1316 | 1.090 |
Why?
|
| Isocitrate Dehydrogenase | 4 | 2018 | 78 | 1.060 |
Why?
|
| Hippocampus | 5 | 2022 | 824 | 0.950 |
Why?
|
| Basal Forebrain | 2 | 2016 | 32 | 0.940 |
Why?
|
| Dementia | 5 | 2024 | 451 | 0.920 |
Why?
|
| alpha-Synuclein | 5 | 2020 | 122 | 0.900 |
Why?
|
| DNA Repeat Expansion | 2 | 2023 | 64 | 0.840 |
Why?
|
| Brain | 11 | 2021 | 3015 | 0.790 |
Why?
|
| Middle Cerebellar Peduncle | 1 | 2022 | 1 | 0.790 |
Why?
|
| Muscle, Skeletal | 2 | 2019 | 945 | 0.790 |
Why?
|
| Neuropathology | 1 | 2022 | 7 | 0.780 |
Why?
|
| Brain Diseases | 2 | 2017 | 300 | 0.780 |
Why?
|
| Motor Neuron Disease | 1 | 2021 | 15 | 0.760 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2021 | 19 | 0.760 |
Why?
|
| Aged | 27 | 2023 | 19666 | 0.740 |
Why?
|
| Amygdala | 2 | 2022 | 80 | 0.740 |
Why?
|
| Amyloid beta-Peptides | 5 | 2021 | 212 | 0.730 |
Why?
|
| Myositis, Inclusion Body | 1 | 2020 | 8 | 0.700 |
Why?
|
| Limbic Encephalitis | 1 | 2020 | 4 | 0.680 |
Why?
|
| Biomarkers, Tumor | 4 | 2016 | 1534 | 0.660 |
Why?
|
| Chorea | 1 | 2020 | 39 | 0.660 |
Why?
|
| Motor Neurons | 1 | 2020 | 138 | 0.650 |
Why?
|
| Hodgkin Disease | 1 | 2021 | 290 | 0.620 |
Why?
|
| Stuttering | 2 | 2010 | 5 | 0.620 |
Why?
|
| Aged, 80 and over | 17 | 2024 | 6543 | 0.620 |
Why?
|
| Multiple System Atrophy | 2 | 2016 | 17 | 0.610 |
Why?
|
| Glioma | 2 | 2013 | 513 | 0.590 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2018 | 27 | 0.580 |
Why?
|
| Dystonia | 1 | 2020 | 171 | 0.580 |
Why?
|
| tau Proteins | 3 | 2024 | 207 | 0.570 |
Why?
|
| Frontotemporal Dementia | 3 | 2022 | 43 | 0.550 |
Why?
|
| Humans | 58 | 2024 | 125138 | 0.540 |
Why?
|
| Male | 39 | 2024 | 61465 | 0.520 |
Why?
|
| Neurons | 4 | 2024 | 1933 | 0.500 |
Why?
|
| Middle Aged | 19 | 2023 | 26688 | 0.500 |
Why?
|
| Brain Mapping | 4 | 2011 | 398 | 0.500 |
Why?
|
| Astrocytes | 1 | 2018 | 251 | 0.480 |
Why?
|
| Female | 37 | 2024 | 66719 | 0.480 |
Why?
|
| Pituitary Neoplasms | 1 | 2016 | 79 | 0.480 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 249 | 0.470 |
Why?
|
| Sarcoma, Alveolar Soft Part | 1 | 2014 | 10 | 0.460 |
Why?
|
| DNA Repair | 1 | 2018 | 591 | 0.460 |
Why?
|
| Chromatin | 1 | 2018 | 579 | 0.460 |
Why?
|
| Mutation | 7 | 2022 | 5906 | 0.450 |
Why?
|
| Glioblastoma | 1 | 2018 | 347 | 0.450 |
Why?
|
| DNA Mutational Analysis | 2 | 2013 | 810 | 0.440 |
Why?
|
| Diagnosis, Differential | 4 | 2017 | 1893 | 0.420 |
Why?
|
| Aging | 3 | 2024 | 1181 | 0.420 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2011 | 81 | 0.420 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2022 | 3606 | 0.420 |
Why?
|
| Hypothalamus | 1 | 2014 | 211 | 0.410 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2012 | 225 | 0.400 |
Why?
|
| Astrocytoma | 1 | 2013 | 106 | 0.400 |
Why?
|
| Sclerosis | 5 | 2022 | 35 | 0.390 |
Why?
|
| Pinealoma | 1 | 2012 | 22 | 0.380 |
Why?
|
| Neoplasms, Neuroepithelial | 1 | 2012 | 12 | 0.380 |
Why?
|
| Inclusion Bodies | 3 | 2017 | 48 | 0.370 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2013 | 223 | 0.370 |
Why?
|
| Fatal Outcome | 3 | 2021 | 357 | 0.360 |
Why?
|
| Functional Laterality | 3 | 2013 | 185 | 0.360 |
Why?
|
| Apolipoproteins E | 2 | 2021 | 192 | 0.350 |
Why?
|
| Immunocompromised Host | 1 | 2013 | 293 | 0.350 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 142 | 0.340 |
Why?
|
| Adult | 20 | 2021 | 29470 | 0.340 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2013 | 293 | 0.330 |
Why?
|
| Tauopathies | 2 | 2024 | 63 | 0.330 |
Why?
|
| Immunohistochemistry | 4 | 2018 | 1704 | 0.320 |
Why?
|
| Cerebral Cortex | 3 | 2013 | 454 | 0.320 |
Why?
|
| Somatosensory Cortex | 1 | 2007 | 53 | 0.280 |
Why?
|
| Frontal Lobe | 1 | 2007 | 116 | 0.270 |
Why?
|
| Positron-Emission Tomography | 3 | 2022 | 306 | 0.270 |
Why?
|
| Sex Characteristics | 1 | 2007 | 314 | 0.250 |
Why?
|
| Nerve Tissue Proteins | 2 | 2022 | 1130 | 0.250 |
Why?
|
| Motor Cortex | 2 | 2021 | 76 | 0.250 |
Why?
|
| Disease Progression | 3 | 2021 | 2084 | 0.240 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2020 | 746 | 0.240 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2020 | 560 | 0.230 |
Why?
|
| Pick Disease of the Brain | 1 | 2024 | 2 | 0.230 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2011 | 586 | 0.220 |
Why?
|
| Membrane Proteins | 2 | 2022 | 1538 | 0.220 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2012 | 374 | 0.210 |
Why?
|
| Autopsy | 3 | 2023 | 110 | 0.210 |
Why?
|
| Neoplasm Proteins | 2 | 2020 | 682 | 0.210 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2014 | 124 | 0.210 |
Why?
|
| Urinary Incontinence | 1 | 2023 | 70 | 0.200 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2014 | 215 | 0.190 |
Why?
|
| Pons | 1 | 2022 | 33 | 0.190 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2014 | 240 | 0.190 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2021 | 1 | 0.190 |
Why?
|
| Sulfonylurea Receptors | 1 | 2021 | 13 | 0.190 |
Why?
|
| Speech | 1 | 2022 | 62 | 0.190 |
Why?
|
| Protein Aggregates | 2 | 2020 | 30 | 0.190 |
Why?
|
| Aphasia, Primary Progressive | 1 | 2021 | 6 | 0.190 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2020 | 8 | 0.180 |
Why?
|
| Proteostasis Deficiencies | 1 | 2020 | 5 | 0.180 |
Why?
|
| Trochlear Nerve Diseases | 1 | 2020 | 5 | 0.170 |
Why?
|
| Anisotropy | 2 | 2011 | 124 | 0.170 |
Why?
|
| Ankyrins | 1 | 2021 | 95 | 0.170 |
Why?
|
| Potassium Channels | 1 | 2021 | 161 | 0.170 |
Why?
|
| Nervous System Malformations | 1 | 2022 | 130 | 0.170 |
Why?
|
| Neurocysticercosis | 1 | 2020 | 27 | 0.170 |
Why?
|
| Interneurons | 1 | 2021 | 145 | 0.170 |
Why?
|
| Cerebellum | 2 | 2022 | 441 | 0.160 |
Why?
|
| F-Box Proteins | 1 | 2020 | 35 | 0.160 |
Why?
|
| Autoantigens | 1 | 2020 | 118 | 0.160 |
Why?
|
| Neoplasm Staging | 2 | 2013 | 1275 | 0.160 |
Why?
|
| Nerve Degeneration | 1 | 2020 | 121 | 0.150 |
Why?
|
| Membrane Glycoproteins | 1 | 2021 | 413 | 0.150 |
Why?
|
| Reproducibility of Results | 3 | 2011 | 2878 | 0.150 |
Why?
|
| Mitochondria | 2 | 2022 | 680 | 0.150 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2018 | 43 | 0.150 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2018 | 13 | 0.150 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2018 | 13 | 0.150 |
Why?
|
| Nervous System Diseases | 1 | 2022 | 373 | 0.150 |
Why?
|
| Proteins | 1 | 2023 | 1040 | 0.150 |
Why?
|
| Corpus Striatum | 1 | 2018 | 93 | 0.150 |
Why?
|
| Locomotion | 1 | 2018 | 67 | 0.150 |
Why?
|
| Mucin-1 | 1 | 2018 | 35 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 80 | 0.140 |
Why?
|
| Genes, Neoplasm | 1 | 2018 | 83 | 0.140 |
Why?
|
| Microscopy, Electron | 1 | 2018 | 396 | 0.140 |
Why?
|
| Autoimmune Diseases | 1 | 2020 | 251 | 0.140 |
Why?
|
| Neostriatum | 1 | 2017 | 11 | 0.140 |
Why?
|
| Mitosis | 1 | 2018 | 241 | 0.140 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 433 | 0.140 |
Why?
|
| Autoantibodies | 1 | 2020 | 433 | 0.130 |
Why?
|
| Protein Folding | 1 | 2018 | 216 | 0.130 |
Why?
|
| Brain Chemistry | 1 | 2017 | 126 | 0.130 |
Why?
|
| Cognition Disorders | 2 | 2020 | 547 | 0.130 |
Why?
|
| Spinal Cord Diseases | 1 | 2017 | 37 | 0.130 |
Why?
|
| Adrenergic Neurons | 1 | 2016 | 5 | 0.130 |
Why?
|
| Medulla Oblongata | 1 | 2016 | 22 | 0.130 |
Why?
|
| Serotonergic Neurons | 1 | 2016 | 22 | 0.130 |
Why?
|
| Age Factors | 3 | 2020 | 2815 | 0.130 |
Why?
|
| Eye | 1 | 2018 | 228 | 0.130 |
Why?
|
| Keratin-20 | 1 | 2016 | 13 | 0.130 |
Why?
|
| Keratin-7 | 1 | 2016 | 7 | 0.130 |
Why?
|
| Thyroid Nuclear Factor 1 | 1 | 2016 | 14 | 0.130 |
Why?
|
| PAX8 Transcription Factor | 1 | 2016 | 14 | 0.130 |
Why?
|
| Oligodendroglioma | 1 | 2016 | 23 | 0.130 |
Why?
|
| Synapses | 1 | 2020 | 452 | 0.130 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2016 | 38 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2014 | 177 | 0.130 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2014 | 772 | 0.130 |
Why?
|
| Gliosarcoma | 1 | 2015 | 10 | 0.120 |
Why?
|
| Inflammation | 2 | 2021 | 1447 | 0.120 |
Why?
|
| Parkinson Disease | 1 | 2022 | 690 | 0.120 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2017 | 185 | 0.120 |
Why?
|
| Thrombosis | 3 | 2005 | 520 | 0.120 |
Why?
|
| Cost of Illness | 1 | 2017 | 251 | 0.120 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2016 | 69 | 0.120 |
Why?
|
| Lewy Body Disease | 1 | 2015 | 19 | 0.120 |
Why?
|
| Pineal Gland | 1 | 2015 | 20 | 0.120 |
Why?
|
| Chemoradiotherapy | 1 | 2016 | 104 | 0.120 |
Why?
|
| Young Adult | 5 | 2018 | 9060 | 0.120 |
Why?
|
| Membrane Transport Proteins | 1 | 2016 | 174 | 0.120 |
Why?
|
| Methotrexate | 1 | 2017 | 336 | 0.120 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 37 | 0.120 |
Why?
|
| Hemostasis | 2 | 2005 | 70 | 0.110 |
Why?
|
| Electronic Health Records | 2 | 2018 | 721 | 0.110 |
Why?
|
| Phosphorylation | 1 | 2018 | 1640 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 578 | 0.110 |
Why?
|
| Genetic Pleiotropy | 1 | 2013 | 24 | 0.110 |
Why?
|
| Leukemia | 1 | 2017 | 367 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2016 | 367 | 0.110 |
Why?
|
| Leg | 1 | 2014 | 154 | 0.110 |
Why?
|
| Repressor Proteins | 1 | 2018 | 827 | 0.110 |
Why?
|
| Antigens, Neoplasm | 1 | 2016 | 384 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 584 | 0.110 |
Why?
|
| Adolescent | 4 | 2016 | 19424 | 0.100 |
Why?
|
| Chromosomes, Human, X | 1 | 2014 | 158 | 0.100 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2013 | 105 | 0.100 |
Why?
|
| Neuroglia | 1 | 2015 | 207 | 0.100 |
Why?
|
| Dermatomyositis | 1 | 2013 | 21 | 0.100 |
Why?
|
| Phenotype | 2 | 2020 | 4271 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2012 | 63 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2014 | 430 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2016 | 794 | 0.100 |
Why?
|
| Rhabdomyosarcoma | 1 | 2015 | 191 | 0.100 |
Why?
|
| Algorithms | 2 | 2010 | 1630 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2012 | 140 | 0.100 |
Why?
|
| Neuroanatomy | 1 | 2011 | 12 | 0.100 |
Why?
|
| Third Ventricle | 1 | 2012 | 28 | 0.100 |
Why?
|
| Translocation, Genetic | 1 | 2014 | 358 | 0.100 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 193 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2013 | 173 | 0.090 |
Why?
|
| Pattern Recognition, Automated | 1 | 2011 | 49 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2018 | 2814 | 0.090 |
Why?
|
| Risk Factors | 2 | 2024 | 10284 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2014 | 771 | 0.090 |
Why?
|
| Gene Frequency | 1 | 2012 | 729 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2016 | 1035 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2011 | 256 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2022 | 16350 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 1592 | 0.080 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 439 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 1284 | 0.080 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 653 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 2907 | 0.080 |
Why?
|
| Image Enhancement | 1 | 2010 | 163 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2011 | 193 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2014 | 1563 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1910 | 0.070 |
Why?
|
| Efferent Pathways | 1 | 2008 | 8 | 0.070 |
Why?
|
| Blood Platelets | 3 | 2005 | 325 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2022 | 4824 | 0.070 |
Why?
|
| Zebrafish | 3 | 2005 | 380 | 0.070 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2008 | 71 | 0.070 |
Why?
|
| Observer Variation | 1 | 2007 | 300 | 0.070 |
Why?
|
| Models, Neurological | 1 | 2008 | 216 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2016 | 2603 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 2056 | 0.060 |
Why?
|
| Limbic System | 1 | 2024 | 22 | 0.060 |
Why?
|
| Animals | 8 | 2021 | 34304 | 0.060 |
Why?
|
| Prognosis | 1 | 2013 | 4685 | 0.060 |
Why?
|
| Embolism | 1 | 2004 | 46 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 2414 | 0.050 |
Why?
|
| Haplotypes | 1 | 2024 | 521 | 0.050 |
Why?
|
| Receptors, GABA | 1 | 2022 | 17 | 0.050 |
Why?
|
| Detergents | 1 | 2021 | 24 | 0.050 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 64 | 0.050 |
Why?
|
| Amyloid | 1 | 2022 | 65 | 0.050 |
Why?
|
| Apolipoprotein E4 | 1 | 2021 | 45 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 5169 | 0.050 |
Why?
|
| Arterioles | 1 | 2020 | 28 | 0.040 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2020 | 13 | 0.040 |
Why?
|
| Neurofibrillary Tangles | 1 | 2020 | 26 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2024 | 780 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2020 | 48 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2020 | 58 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2020 | 133 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2020 | 402 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2020 | 174 | 0.040 |
Why?
|
| Cell Death | 1 | 2020 | 239 | 0.040 |
Why?
|
| Mice | 3 | 2021 | 17739 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2020 | 626 | 0.040 |
Why?
|
| Claudin-1 | 1 | 2018 | 20 | 0.040 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2018 | 24 | 0.040 |
Why?
|
| Infant | 1 | 2013 | 12611 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2018 | 122 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2018 | 106 | 0.040 |
Why?
|
| Peripheral Nerves | 1 | 2018 | 84 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2013 | 14155 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2020 | 344 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 3176 | 0.030 |
Why?
|
| Subacute Combined Degeneration | 1 | 2017 | 1 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 461 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2020 | 874 | 0.030 |
Why?
|
| Alleles | 1 | 2021 | 1617 | 0.030 |
Why?
|
| Raphe Nuclei | 1 | 2016 | 17 | 0.030 |
Why?
|
| Injections, Spinal | 1 | 2017 | 126 | 0.030 |
Why?
|
| Hypotension, Orthostatic | 1 | 2016 | 21 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1242 | 0.030 |
Why?
|
| Laryngeal Diseases | 1 | 2016 | 32 | 0.030 |
Why?
|
| Homocysteine | 1 | 2017 | 115 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 456 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2018 | 455 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 2016 | 70 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 372 | 0.030 |
Why?
|
| Genotype | 1 | 2021 | 2570 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1756 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2016 | 96 | 0.030 |
Why?
|
| S100 Proteins | 1 | 2015 | 46 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2015 | 114 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2016 | 101 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2015 | 106 | 0.030 |
Why?
|
| Folic Acid | 1 | 2017 | 293 | 0.030 |
Why?
|
| Melanins | 1 | 2014 | 18 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3403 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 1694 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2015 | 284 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 2458 | 0.030 |
Why?
|
| Fingers | 1 | 2013 | 65 | 0.030 |
Why?
|
| Child | 1 | 2013 | 24620 | 0.030 |
Why?
|
| Mouth | 1 | 2013 | 62 | 0.030 |
Why?
|
| Nephrectomy | 1 | 2014 | 176 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2013 | 122 | 0.030 |
Why?
|
| Biomarkers | 1 | 2021 | 3105 | 0.020 |
Why?
|
| Movement | 1 | 2013 | 172 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2014 | 323 | 0.020 |
Why?
|
| Mexican Americans | 1 | 2013 | 202 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2015 | 1496 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2011 | 40 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1319 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1757 | 0.020 |
Why?
|
| Pedigree | 1 | 2013 | 1610 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 442 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2015 | 12276 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2010 | 470 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2010 | 650 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2096 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2005 | 13 | 0.020 |
Why?
|
| Lasers | 1 | 2005 | 114 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2005 | 312 | 0.010 |
Why?
|
| Arteries | 1 | 2005 | 218 | 0.010 |
Why?
|
| Blood Coagulation Tests | 1 | 2004 | 62 | 0.010 |
Why?
|
| Cellular Senescence | 1 | 2005 | 163 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 262 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2004 | 102 | 0.010 |
Why?
|
| Transgenes | 1 | 2005 | 336 | 0.010 |
Why?
|
| Larva | 1 | 2004 | 248 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2004 | 347 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 331 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2004 | 371 | 0.010 |
Why?
|